Amazon Beats Q2 Estimates but Disappoints with Q3 Operating Income Outlook; Shares Drop Over 7% After Hours

Paul Lee 특파원 / 기사승인 : 2025-08-01 07:29:51
  • -
  • +
  • 인쇄

Photo courtesy of Yonhap News

 

 

[Alpha Biz= Paul Lee] SEATTLE – Amazon reported second-quarter results on July 31 that exceeded Wall Street expectations on both earnings and revenue, but issued a weaker-than-expected operating income forecast for Q3, sending shares down more than 7% in after-hours trading.



For Q2 2024, Amazon posted:

Earnings per share (EPS): $1.68 (vs. $1.33 consensus, LSEG)

Revenue: $167.7 billion (vs. $162.09 billion expected), up 13% year-over-year



Key segment highlights:

Amazon Web Services (AWS): $30.87B revenue (+18% YoY, in line with estimates)

Advertising revenue: $15.7B (+23% YoY, beating $14.99B estimate)

Online store revenue: $61.5B (+11% YoY, above $59B forecast)

Third-party seller services: $40.3B (+11% YoY, above $38.7B forecast)



Despite AWS maintaining its status as the world’s No.1 cloud platform, its growth lags rivals: Microsoft Azure grew 39% last quarter, and Google Cloud grew 32%.



For Q3, Amazon guided:

Operating income: $15.5B–$20.5B (midpoint $18.0B vs. $19.48B expected)



Revenue: $174B–$179.5B (10–13% YoY growth; even the low end surpasses $173.1B consensus)



The subdued profit outlook disappointed investors expecting faster payoffs from Amazon’s massive AI investments. The company plans to spend up to $100 billion this year on data centers and software infrastructure to accelerate its AI capabilities.



Amazon’s stock closed the regular session up 1.7% at $234.11, but dropped over 7% in after-hours trading following the earnings release.
 

 

 

 

알파경제 Paul Lee 특파원(hoondork1977@alphabiz.co.kr)

어플

주요기사

Amazon Shares Soar 9% After AI-Driven AWS Growth Pushes Earnings Far Beyond Expectations2025.10.31
China Officially Confirms Xi–Trump Summit to Be Held in Busan on October 302025.10.30
NVIDIA CEO Jensen Huang Hints at “Exciting Announcement” for South Korea During GTC 20252025.10.29
Novartis to Acquire Avidity Biosciences for USD 12 Billion, Strengthening RNA Therapeutics Portfolio2025.10.28
Target to Cut 1,800 Corporate Jobs Amid Prolonged Sales Slump2025.10.24
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사